| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
|
Hansildaar, Romy
|
|
|
3 |
1 |
p. e58-e70
|
artikel
|
| 2 |
Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective
|
Mackie, Sarah L
|
|
|
3 |
1 |
p. e71-e82
|
artikel
|
| 3 |
COVID-19 in axial spondyloarthritis care provision: helping to straighten the long and winding road
|
Marzo-Ortega, Helena
|
|
|
3 |
1 |
p. e11-e13
|
artikel
|
| 4 |
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform
|
Rentsch, Christopher T
|
|
|
3 |
1 |
p. e19-e27
|
artikel
|
| 5 |
First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection
|
Perrot, Lea
|
|
|
3 |
1 |
p. e6-e8
|
artikel
|
| 6 |
Hydroxychloroquine in the prevention of COVID-19 mortality
|
Jorge, April
|
|
|
3 |
1 |
p. e2-e3
|
artikel
|
| 7 |
Inclusion body myositis: small steps towards future advances
|
Savelieff, Masha G
|
|
|
3 |
1 |
p. e5-e6
|
artikel
|
| 8 |
Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma
|
Mehta, Puja
|
|
|
3 |
1 |
p. e9-e10
|
artikel
|
| 9 |
“I still struggle to accept this condition”
|
Morgan, Jules
|
|
|
3 |
1 |
p. e18
|
artikel
|
| 10 |
Research in Brief
|
Thorley, Jennifer
|
|
|
3 |
1 |
p. e17
|
artikel
|
| 11 |
SARS-CoV-2 serological cross-reactivity with autoantibodies
|
Choy, Kay Weng
|
|
|
3 |
1 |
p. e15
|
artikel
|
| 12 |
SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
|
Teng, Jialin
|
|
|
3 |
1 |
p. e16
|
artikel
|
| 13 |
Serious postoperative complications and reoperation after carpal tunnel decompression surgery in England: a nationwide cohort analysis
|
Lane, Jennifer C E
|
|
|
3 |
1 |
p. e49-e57
|
artikel
|
| 14 |
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial
|
Benveniste, Olivier
|
|
|
3 |
1 |
p. e40-e48
|
artikel
|
| 15 |
Time to end the global neglect of rehabilitation
|
The Lancet Rheumatology,
|
|
|
3 |
1 |
p. e1
|
artikel
|
| 16 |
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
|
Nash, Peter
|
|
|
3 |
1 |
p. e28-e39
|
artikel
|
| 17 |
Tofacitinib monotherapy in psoriatic arthritis—what is missing?
|
Fleischmann, Roy
|
|
|
3 |
1 |
p. e3-e5
|
artikel
|
| 18 |
Vagus nerve stimulation in rheumatoid arthritis
|
Staats, Peter S
|
|
|
3 |
1 |
p. e14
|
artikel
|
| 19 |
Vagus nerve stimulation in rheumatoid arthritis – Authors' reply
|
Genovese, Mark C
|
|
|
3 |
1 |
p. e14-e15
|
artikel
|
Tijdschrift beschrijving